Healthcare
CVC invests in FutureLife
CVC acquires a co-controlling stake alongside current investor Hartenberg Holding
Korify launches debut VC fund with USD 100m target
Vehicle will back biotechnology companies focusing on mental illnesses and age-related diseases
Pureos Bioventures to raise new fund in 2022
VC firm will likely start fundraising next year once its first fund is fully invested
ArchiMed preps Bomi auction
ArchiMed launched a EUR 70m takeover bid for Bomi in March 2019
Triton to buy Clinigen in GBP 1.2bn deal
Board of the UK-based listed pharmaceuticals company has agreed to the offer
MTIP holds USD 250m final close for second fund
Health technology firm has made five deals from the fund and expects to back 10 companies in total
Apax sells Unilabs to AP Moller
Laboratory and imaging diagnostics service is valued at more than EUR 5bn
Vivalto Partners buys majority stake in Vivalto Santé
New investors IK Partners and Hayfin are backing the deal, as well as incumbents such as Mubadala
VCs in USD 156m round for Quell Therapeutics
Series B for the Treg therapy developer was led by VCs including Jeito Capital and Ridgeback Capital
PAI, OTPP join forces in final leg of Veonet auction
Consortium may be well placed to clinch a deal for the Nordic Capital- and Palamon-backed ophthalmology group
First bids due for TA's Laboratoires Vivacy
TA Associates made an undisclosed investment in Vivacy in 2019
Capiton holds EUR 504m final close for sixth fund
Capiton VI is now 36% deployed across seven deals and expects to make up to 15 platform investments
IK, Asian strategics in final sale round for Schwind
Sell side is aiming to deliver on high price expectations for the asset
G Square transfers ISPS to new fund after sale talks with PAI collapse
Sponsor refinanced the business with incumbent lender CVC and another direct lender as part of the transfer
ArchiMed buys Cardioline
Cardiology telemedicine platform is the first deal from the GP's EUR 650m MED III fund
GP Profile: Adelis steps up deal-making after latest fund close
Co-managing partner Jan Åkesson and head of IR Adalbjörn Stefansson speak to Unquote about the Nordic mid-market-focused GP's fundraise and deployment plans
Adelis III holds EUR 932m final close
Stockholm-headquartered GP's predecessor fund held a final close in 2017 on EUR 600m
EQT acquires LSP, forming EQT Life Sciences
Announcement follows Life Sciences Partners' seven-month, EUR 850m fundraise for LSP VII
PAI exits Atos Medical in EUR 2.2bn trade sale
PAI acquired the laryngotomy and tracheostomy care products company in an SBO from EQT in 2017
Ardian, Latour buy LBO France's Groupe RG
LBO France bought a majority stake in the personal protective equipment producer in 2017
ArchiMed's MED II fund fully invested following Cube buyout
Cube is the last platform investment for the MED II fund, which closed in 2017
HealthCap looks to future growth after new appointments
Venture capital firm HealthCap is looking ahead to a busy healthcare and life sciences market
GHO appoints new director of sustainable investing
GHO creates the new role in order to further institutionalise its commitment to ESG
Aurelius buys McKesson UK in GBP 477m deal
Carve-out of McKesson UK includes LloydsPharmacy and is Aurelius's largest deal to date